Ahmadi A, Bongso A, Ng S C
Department of Obstetrics & Gynaecology, National University of Singapore, Singapore.
J Assist Reprod Genet. 1996 Sep;13(8):647-51. doi: 10.1007/BF02069643.
Our objective was to investigate the fertilizing ability of human sperm from severe male-factor patients, by microinjection of single sperm into the hamster oocyte.
Semen samples of severe male factor either with a 0% penetration rate in the zona-free hamster test or with a very low number of motile sperm for which performing the standard penetration test was impossible were used. For the control study, oligozoospermic semen samples with at least 10% penetration rate in zona free hamster test were used.
All materials were collected from the National University Hospital, Singapore.
There were 10 patients in both the experimental and the control groups. Intracytoplasmic sperm injection (ICSI) was carried out. The main outcome measures were sperm head decondensation and pronuclear formation.
Twenty-one percent of the injected sperm could decondense and undergo male pronuclear formation. This rate was not significantly different from that in the control study group (28%; P = 0.13). A small proportion of the oocytes was damaged during the procedure (9.2 and 8.75% in experimental and control groups, respectively).
Hamster-ICSI assay may be of benefit in predicting the sperm's ability for further development before allowing the patient to undergo the clinical program.
我们的目的是通过将单个精子显微注射到仓鼠卵母细胞中,研究重度男性因素患者的人类精子受精能力。
使用在无透明带仓鼠试验中穿透率为0%或活动精子数量极少以至于无法进行标准穿透试验的重度男性因素精液样本。作为对照研究,使用在无透明带仓鼠试验中穿透率至少为10%的少精子症精液样本。
所有材料均取自新加坡国立大学医院。
实验组和对照组各有10名患者。进行了卵胞浆内单精子注射(ICSI)。主要观察指标为精子头部解聚和原核形成。
21%的注射精子能够解聚并形成雄原核。该比率与对照研究组(28%)无显著差异(P = 0.13)。在操作过程中有一小部分卵母细胞受损(实验组和对照组分别为9.2%和8.75%)。
仓鼠卵胞浆内单精子注射试验可能有助于在患者进入临床程序之前预测精子的进一步发育能力。